Shiferman Gregory L. — SEC Form 4 filings
SEC reporting owner CIK 2041689. 10 Form 4 filings on record with FilingPulse; latest filed 2026-04-03.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-11-01 to 2026-04-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sage Therapeutics, Inc. (SAGE) | See Remarks | 8 | — | — | 14 |
| Voyager Therapeutics, Inc. (VYGR) | SVP and General Counsel | 2 | — | — | 2 |
Form 4 filings — Shiferman Gregory L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-03 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-01-08 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Sage Therapeutics, Inc. (SAGE) | Code (U): 7,215 · Disposition to issuer (D): 23,735 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 28,000 (derivative) | EDGAR |
| 2025-06-26 | 4 | Sage Therapeutics, Inc. (SAGE) | Tax withholding (F): 79 @ $9.22 | EDGAR |
| 2025-04-11 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 525 @ $0 · Tax withholding (F): 176 @ $6.91 | EDGAR |
| 2025-03-26 | 4 | Sage Therapeutics, Inc. (SAGE) | Tax withholding (F): 79 @ $8.21 | EDGAR |
| 2025-02-25 | 4 | Sage Therapeutics, Inc. (SAGE) | Tax withholding (F): 2,502 @ $7.49 | EDGAR |
| 2025-02-14 | 4 | Sage Therapeutics, Inc. (SAGE) | Tax withholding (F): 376 @ $7.18 · Tax withholding (F): 251 @ $7.18 | EDGAR |
| 2024-12-27 | 4 | Sage Therapeutics, Inc. (SAGE) | Tax withholding (F): 79 @ $5.48 | EDGAR |
| 2024-11-01 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2041689 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →